Corporate News     05-Jul-23
Biocon Biologics completes integration of Viatris' biosimilars biz in over 70 countries
Biocon Biologics, a subsidiary of Biocon today announced that the company has completed the integration of the acquired biosimilars business in over 70 countries in Emerging Markets effective 01 July 2023, increasing the scale and scope of its business.

Following the deal closure in November 2022, this marks the first wave of countries where Viatris' operations have fully transitioned to Biocon Biologics. A robust integration plan has ensured a seamless transition of partners, people, systems, and processes across these countries.

The existing commercialized portfolio of biosimilars, including bTrastuzumab, bPegfilgrastim, bBevacizumab, bGlargine, bAspart, bAdalimumab, and bEtanercept, managed by Viatris in these markets, is now a part of Biocon Biologics' commercial organization.

'We will work with existing and new partners to expand our footprint and strengthen our business presence in these countries. Our best-in-class R&D capabilities, high-quality manufacturing, supply chain excellence, and commercial and regulatory expertise will enable us to expand access to a diverse portfolio of biosimilars, meet patients' needs and be a trusted partner to patients and the healthcare community in these markets.', the company commented.

Previous News
  Biocon
 ( Results - Analysis 17-May-24   10:41 )
  Biocon Ltd spurts 1.22%, gains for third straight session
 ( Hot Pursuit - 07-Jun-24   13:05 )
  Biocon to conduct board meeting
 ( Corporate News - 18-Jul-24   10:37 )
  Biocon receives reaffirmation in credit rating for bank facilities
 ( Corporate News - 30-Nov-23   15:49 )
  Biocon announces resignation of senior management
 ( Corporate News - 08-Feb-24   19:49 )
  Biocon Ltd soars 1.22%, rises for fifth straight session
 ( Hot Pursuit - 27-Mar-24   13:00 )
  Biocon Biologics completes integration of Viatris' biosimilars business in 31 European countries
 ( Corporate News - 30-Nov-23   16:49 )
  Biocon consolidated net profit declines 29.78% in the June 2023 quarter
 ( Results - Announcements 11-Aug-23   07:47 )
  Biocon Biologics divests its non-crore branded formulations biz in India
 ( Corporate News - 10-Nov-23   12:06 )
  Biocon CFO resigns
 ( Corporate News - 08-Feb-24   19:43 )
  Board of Biocon appoints director
 ( Corporate News - 27-Jul-23   12:46 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top